Nutritional therapy with omega-3 for lung cancer surgery patients
Effect of Perioperative Nutrition Enriched With Omega-3 on the Incidence of Infections in Oncologic Patients Following Lung Resection
This study is testing if giving lung cancer surgery patients an omega-3 enriched nutritional formula can help reduce infections and improve recovery after their surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 310 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | National Institute of Respiratory Diseases, Mexico Government |
| Locations | 1 site (Mexico City) |
| Trial ID | NCT06531460 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of an omega-3 enriched nutritional formula on the incidence of infections and inflammatory responses in lung cancer patients undergoing lung resection surgery. Participants will receive either fish oil enteral supplementation, fish oil oral supplementation, or standard nutritional support without fish oil. The goal is to determine if omega-3 can improve postoperative outcomes within 30 days following surgery. The study aims to enhance prehabilitation nutrition strategies for better recovery in this patient population.
Who should consider this trial
Good fit: Ideal candidates include lung cancer patients scheduled for elective lung resection surgery who can provide informed consent.
Not a fit: Patients with acute or chronic organ failure, fish allergies, recent surgeries, or those who are immunocompromised may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could reduce postoperative infections and improve recovery outcomes for lung cancer patients undergoing surgery.
How similar studies have performed: While the specific combination of omega-3 and lung resection is novel, previous studies have shown potential benefits of omega-3 in improving surgical outcomes in various patient populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Lung cancer diagnosis * Elective surgery for lung resection schedule at least four days before surgery * Signed informed consent. Exclusion Criteria: * Acute or chronic organ failure as hepatic or renal insufficiency * Patients with fish-allergy * History of any surgery within 3 months * Immunocompromised patients
Where this trial is running
Mexico City
- National Institute of Respiratory Diseases — Mexico City, Mexico (Recruiting)
Study contacts
- Principal investigator: Ivan A Osuna-Padilla, PhD — Instituto Nacional de Enfermedades Respiratorias
- Study coordinator: Ivan A Osuna-Padilla, PhD
- Email: ivan.osuna@iner.gob.mx
- Phone: 5487-1700
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.